Neurocrine Biosciences
NBIX
NBIX
570 hedge funds and large institutions have $12.4B invested in Neurocrine Biosciences in 2025 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 220 increasing their positions, 215 reducing their positions, and 69 closing their positions.
Holders
570
Holders Change
-7
Holders Change %
-1.21%
% of All Funds
7.66%
Holding in Top 10
15
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+50%
% of All Funds
0.2%
New
76
Increased
220
Reduced
215
Closed
69
Calls
$23.3M
Puts
$17.1M
Net Calls
+$6.14M
Net Calls Change
-$22M
Top Buyers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$536M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$388M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$258M |
4 |
RI
4
RTW Investments
New York
|
$133M |
5 |
5
Norges Bank
Oslo,
Norway
|
$122M |